August 13, 2024Today, the Centers for Medicare and Medicaid Services (CMS) released the Maximum Fair Prices (MFPs) for 10 selected medicines to go into effect in 2026. PILMA reiterates our opposition to MFPs, which are simply government price controls on medicines in Medicare under the guise of negotiation. PILMA has long opposed price controls in […]
News
STATEMENT Supporting the House Oversight Committee Hearings on PBM Transparency and Accountability
July 23, 2024 The labor and industry partners of the Pharmaceutical Industry Labor- Management Association (PILMA) applaud the House Oversight Committee’s investigation into the role of PBMs in prescription drug markets. PILMA has a long history of supporting increased transparency and accountability in the prescription drug supply chain and has repeatedly called on lawmakers to […]
THE MIDDLEMEN: The Opaque Industry Secretly Inflating Prices for Prescription DrugsPharmacy benefit managers are driving up drug costs for millions of people, employers and the government.
By Rebecca Robbins and Reed Abelson This is the first article in a series about how pharmacy benefit managers prioritize their interests, often at the expense of patients, employers and taxpayers. Americans are paying too much for prescription drugs. It is a common, longstanding complaint. And the culprits seem obvious: Drug companies. Insurers. A dysfunctional federal government. But […]
Senate Judiciary Committee Hearing: Ensuring Affordable & Accessible Medications: Examining Competition in the Prescription Drug Market
Thank you, Chair Durbin, Ranking Member Graham, and members of the Senate Judiciary Committee, for holding this important hearing today. We appreciate the Committee’s leadership in exploring opportunities to ensure affordable and accessible medications. We share the perspective raised by several witnesses that a healthy prescription drug market rests on strong and dependable intellectual property […]
STATEMENT in Recognition of World IP Day
April 26, 2024 The Pharmaceutical Industry Labor-Management Association (PILMA) is proud to join stakeholders from across the biopharmaceutical and labor communities in recognizing World Intellectual Property Day. Today is an opportunity to reflect on the pivotal role of intellectual property (IP) rights in not only powering innovation and the development of new cures, but in […]
COMMENT to National Institute of Standards and Technology on the Negative Implications of March-in Rights
On February 6, 2024 PILMA submitted the following comment on the Negative Implicants of March-in Rights. PILMA writes to express concern over the administration’s intention to use the Bayh-Dole Act to seize drug patents. PILMA is a coalition between unions in the building and construction trades and biopharmaceutical companies dedicated to creating union jobs and […]